Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Feb 12, 2021 $156.18 $158.56 $156.14 $158.39 1 964 556
Feb 11, 2021 $154.99 $155.43 $153.59 $154.59 1 621 082
Feb 10, 2021 $156.08 $156.63 $154.12 $154.58 1 555 985
Feb 09, 2021 $154.51 $155.80 $154.44 $155.27 1 916 902
Feb 08, 2021 $154.74 $155.76 $154.27 $154.50 1 917 242
Feb 05, 2021 $155.13 $155.26 $153.81 $153.92 2 210 233
Feb 04, 2021 $155.35 $156.28 $155.10 $155.59 4 266 465
Feb 03, 2021 $155.00 $155.50 $154.20 $154.74 1 894 271
Feb 02, 2021 $156.31 $156.97 $154.79 $154.86 2 066 028
Feb 01, 2021 $156.40 $156.77 $155.50 $155.70 4 413 393
Jan 29, 2021 $156.47 $156.82 $153.24 $153.33 4 334 205
Jan 28, 2021 $155.94 $158.44 $155.70 $157.29 2 707 387
Jan 27, 2021 $159.77 $159.81 $155.28 $155.69 3 717 777
Jan 26, 2021 $162.25 $162.60 $161.69 $161.75 2 359 760
Jan 25, 2021 $160.59 $161.75 $160.42 $161.32 1 511 342
Jan 22, 2021 $158.36 $160.33 $158.01 $159.73 2 789 197
Jan 21, 2021 $158.24 $158.94 $157.78 $157.86 3 579 306
Jan 20, 2021 $159.10 $159.10 $157.26 $157.74 3 711 227
Jan 19, 2021 $159.00 $159.40 $158.11 $158.71 4 252 168
Jan 15, 2021 $156.50 $157.50 $156.42 $156.70 2 079 937
Jan 14, 2021 $157.36 $158.11 $156.43 $156.65 3 509 557
Jan 13, 2021 $156.53 $157.58 $156.20 $156.44 3 631 738
Jan 12, 2021 $156.62 $156.75 $155.59 $155.59 2 800 855
Jan 11, 2021 $156.88 $157.92 $156.34 $156.50 3 410 627
Jan 08, 2021 $156.79 $157.57 $156.24 $157.35 2 861 583
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT